试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-07
ACTH Treatment of APOL1- Associated Nephropathy
编号:NCT02006849登记状态:入组前撤回企业 / 申办者:Wake Forest University Health Sciences
药物 / 成分:Acthar
登记的停止原因(原文):no enrollment
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-07
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
编号:NCT03024060登记状态:入组前撤回企业 / 申办者:DUSA Pharmaceuticals, Inc.
药物 / 成分:ALA、Vehicle、IBL 20 mW、IBL 10 mW
登记的停止原因(原文):Study withdrawn due to corporate business decision
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
编号:NCT00349401登记状态:入组前撤回企业 / 申办者:Wake Forest University Health Sciences
药物 / 成分:ketorolac、morphine
登记的停止原因(原文):Study was not initiated. No subjects were screened or enrolled.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
编号:NCT00690911登记状态:入组前撤回企业 / 申办者:Wake Forest University
药物 / 成分:adalimumab
登记的停止原因(原文):Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the study started.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Antibiotic Therapy After Incision and Drainage for Abscess
编号:NCT00900510登记状态:入组前撤回企业 / 申办者:Wake Forest University
药物 / 成分:Incision and drainage、Trimethoprim/Sulfamethoxazole (Bactrim)、Placebo
登记的停止原因(原文):Recruitment of this population in the hospital setting not practical.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Wound Healing of Incisional Wounds for Bilateral Hernia Repair
编号:NCT01008111登记状态:入组前撤回企业 / 申办者:Wake Forest University
药物 / 成分:Dermabond、Hydrogen Peroxide Oxygen producing gel
登记的停止原因(原文):study never initiated
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage
编号:NCT01715610登记状态:入组前撤回企业 / 申办者:London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
药物 / 成分:Clavulin、Randomization to Placebo、Clindamycin
登记的停止原因(原文):unsuccessful recruitment
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Prevention of Noise-induced Hearing Loss
编号:NCT02049073登记状态:入组前撤回企业 / 申办者:Washington University School of Medicine
药物 / 成分:Zonisamide、Methylprednisolone
登记的停止原因(原文):new data makes this trial unethical
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.
编号:NCT02405910登记状态:入组前撤回企业 / 申办者:West Virginia University
药物 / 成分:Nab-paclitaxel、Gemcitabine
登记的停止原因(原文):PI Left Institution
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-11-06
Natriuretic Peptides and Metabolic Risk in Obesity
编号:NCT02642523登记状态:入组前撤回企业 / 申办者:Vanderbilt University Medical Center
药物 / 成分:Nesiritide、Insulin、Saline
登记的停止原因(原文):Preliminary data run on rat samples showed that this study question and design would not produce conclusive results. The PI decided not to carry out the study.
查看官方原始记录 ↗